https://orcid.org/0000-0001-6956-8743
Figures & data
Figure 1. The underlying immuno-regulatory mechanisms accompanied by T cell-dependent protective response or chemokine-mediated inflammatory response.
Figure 2. The crosstalk between NK cells, T cells, and DCs induces the innate and adaptive response in SARS-CoV-2-infected patients with mild to moderate symptoms.
Figure 3. The interplay between SARS-CoV-2 and host immune cells in severe COVID-19 infection.
Figure 4. Schematic representation of NK cell-induced antiviral and immuno-regulatory responses.
Figure 5. The idiosyncratic immune-modulatory effect is associated with the paracrine factors produced by MSC-mediated therapy.
Table 1. Examples of ongoing interventional clinical trials registered at ClinicalTrials.gov employ cellular-based therapy to treat and prevent COVID-19 infection.
Figure 6. Schematic representation of various types of cell-based therapies used for prevention or treatment of patients with severe COVID-19, including the strategies to produce these immune cells and their mechanism of actions against SARS-CoV-2 infection.
